Same Target, Opposite Strategy — How a GD2-Directed ADC Cuts Off Neuroblastoma's Energy Supply
Here's a question worth sitting with: when most researchers are debating whether to boost NAD+, a cancer biology team spent 2026 figuring out how to make sure